What's New at CBER

If your email program has trouble displaying this email, view it as a web page

What's New at CBER Dear Colleague, You are subscribed to What's New at CBER for the U.S. Food & Drug Administration (FDA) This following links have been updated recently: Influenza Virus Vaccine for the 2018-2019 Season Posted: 8/30/2018 August 29, 2018 Approval Letter - JIVI (PDF - 58KB) Posted: 8/30/2018 eSubmitter Download and Installation Updated: 8/30/2018; Link to Download Most Common Issues (August 2018) added  Webinar - Writing the "Indications and Usage" Section of Labeling: FDA's New Draft Guidance – September 27 This webinar will provide insight on FDA's recommendations for the "Indications and Usage" section of labeling as outlined in the draft guidance titled "Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products – Content and Format."

U.S. Food and Drug Administration 10903 New Hampshire Avenue, Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332) Privacy Policy | www.fda.gov Manage Preferences or Unsubscribe from this List | Unsubscribe from all Email Lists